in past times number of years, the united kingdom has witnessed a revolution in clinical excess weight‑reduction solutions — within the introduction of semaglutide (Wegovy®) for the developing recognition of tirzepatide (Mounjaro®). Now, Yet another name is drawing consideration in both scientifi